Viewing Study NCT03006432


Ignite Creation Date: 2025-12-24 @ 9:45 PM
Ignite Modification Date: 2026-02-23 @ 11:33 AM
Study NCT ID: NCT03006432
Status: COMPLETED
Last Update Posted: 2025-03-05
First Post: 2016-12-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: PHASE III RANDOMISED TRIAL to EVALUATE FOLFOX with or WITHOUT DOCETAXEL (TFOX) AS 1st LINE CHEMOTHERAPY for LOCALLY ADVANCED or METASTATIC OESOPHAGO-GASTRIC CARCINOMA
Sponsor: Federation Francophone de Cancerologie Digestive
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None OESOPHAGO-GASTRIC CARCINOMA View
Keywords:

Keywords

Keyword Brief Keyword Text View
None OESOPHAGO-GASTRIC CARCINOMA View